As the worlds populations are rapidly heading toward an aging society and human life spans are increasing, this problem will certainly be of greater magnitude in the foreseeable future
Demographic and pathophysiological data were prospectively obtained during routine clinical visits between August 2020 and November 2021
Additionally, when pristine Raw264.7 cells were treated with varying concentrations (0, 3, 6, 12, 25, 50, 75, 100, and 150 g/mL) of PDA and PDA@Pt, the PDA alone did not exhibit a significant decline in cell viability, while the PDA@Pt group showed a minor reduction at high concentrations, suggesting that the nanodrug is virtually non-toxic to normal Raw264.7 cells (Fig
Clinics often administer 600 mg to 1,400 mg per IV session, 1-3 times a week
Treated leaves maintained higher relative water content (RWC) and exhibited reduced electrolyte leakage, reflecting improved membrane integrity